Human Embryos

The practice has a peerless history of involvement in the law and regulation of human embryo research. We advise leading researchers and institutions in connection with matters such as the regulation of synthetic human entities with embryo-like features, hESC patenting, mitochondrial donation and the future regulation of IVF genome editing and ‘14-day limit’.

Clients appreciate not only our pedigree, but also how our understanding of embryology works with our detailed understanding of the regulations and limits of regulatory power.

We advise universities, companies and clinics in relation to applications for HFEA research licences, HFEA licence committee procedures, regulatory investigations and litigation relating to research.